REGENXBIO Inc.

NASDAQ:RGNX

7.41 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013
Revenue 90.242112.724470.347154.56735.233218.50510.3934.5897.5886.126.087
Cost of Revenue 37.21354.54551.83335.7148.2419.641.7090.9591.5031.0070.324
Gross Profit 53.02958.179418.514118.85326.992208.8658.6843.636.0855.1135.763
Gross Profit Ratio 0.5880.5160.890.7690.7660.9560.8360.7910.8020.8350.947
Reseach & Development Expenses 232.266242.453181.437166.294124.18583.87357.22445.48217.2794.9615.051
General & Administrative Expenses 88.49485.28179.33363.81751.81536.8527.22923.5911.9123.8515.474
Selling & Marketing Expenses 00000000000
SG&A 88.49485.28179.33363.81751.81536.8527.22923.5911.9123.8515.474
Other Expenses 0.397-6.679-2.2367.975-0.010.0420.116-0.102-0.026-0.0470
Operating Expenses 321.157321.055258.534238.086175.99120.76584.56968.9729.1658.76510.525
Operating Income -268.128-262.876159.98-119.233-148.99888.1-75.885-65.34-23.137-3.682-4.776
Operating Income Ratio -2.971-2.3320.34-0.771-4.2290.403-7.302-14.238-3.049-0.602-0.785
Total Other Income Expenses Net 4.482-17.529-18.73313.22351.5116.0162.7161.9380.326-0.321-0.611
Income Before Tax -263.646-280.405141.247-106.01-97.488104.116-73.169-63.402-22.811-4.003-5.387
Income Before Tax Ratio -2.922-2.4880.3-0.686-2.7670.476-7.04-13.816-3.006-0.654-0.885
Income Tax Expense -0.152-0.08413.4075.24-2.7554.1790.686-0.435-0.060.2910.597
Net Income -263.494-280.321127.84-111.25-94.73399.937-73.169-62.967-22.811-4.003-5.387
Net Income Ratio -2.92-2.4870.272-0.72-2.6890.457-7.04-13.721-3.006-0.654-0.885
EPS -6.02-6.53.01-2.98-2.582.73-2.45-2.38-2.49-0.3-0.41
EPS Diluted -6.02-6.52.91-2.98-2.582.73-2.45-2.38-2.49-0.3-0.41
EBITDA -239.464-244.242169.544-96.832-90.33692.082-73.199-64.796-22.711-3.652-4.776
EBITDA Ratio -2.654-2.3290.342-0.744-5.6070.371-7.563-14.238-3.042-0.597-0.782